Dr. Frank Borriello to speak at Gamma Delta T Therapies Summit.

July 28, 2022 in Boston.

July 27, 2022. 

Alloplex’s Founder and CEO, Dr. Frank Borriello, will be speaking at the 3rd Gamma Delta T Therapies Summit on Thursday 28th July 2022 at 11 AM in a session titled “Reviewing the clinical safety and efficacy of gamma delta therapies” on the Response in Solid Tumors of Non-Engineered Autologous Multi-Cell Therapy.

Synopsis of Dr. Borriello’s presentation:

  • Outlining the genesis of a multimodal cellular therapy called SUPLEXA
  • Investigating the clinical mechanism of action of multi-modal cellular therapy in coordinating an anti-tumor response
  • Developing an exploratory research program with clinical samples to study this autologous therapy
  • Outlining the clinical observations to date.

Our CSO, Dr. James Lederer, also presented at the pre-conference deep dive day on the 26th on the topic ‘Studying the Mechanisms of Action of Polyfunctional Gamma Delta T Cells’. By all reports, it’s an excellent meeting with great ideas circulating and lots to learn.

“Clearly Gamma T cells have a lot of promise as an anti-tumor therapy and we are glad to be part of the effort to assess this clinical activity”, Dr. Borriello commented.

Register here: https://gamma-delta-t-therapies.com/